Kestra Private Wealth Services’s Avidity Biosciences RNAM Stock Holding History

Kestra Private Wealth Services’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,300	Closed	-$310K	–	1858
2025 Q4	$310K	Buy	+4,300	New	+$278K	﹤0.01%	1406

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Kestra Private Wealth Services's RNAM Position: Q1 2026 in Review

Kestra Private Wealth Services sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,300 shares — an estimated $310K sold.

Kestra Private Wealth Services first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $310K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Kestra Private Wealth Services reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Kestra Private Wealth Services sold 4,300 Avidity Biosciences shares in Q1 2026, an estimated $310K.
Kestra Private Wealth Services first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Kestra Private Wealth Services's Avidity Biosciences position peaked at $310K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.